Call Us Today:
949.200.1600

SCC Keratoacanthoma Type

Home > Diagnosis > Squamous Cell Carcinoma > SCC Keratoacanthoma Type

Skin-Cancer-Specialists-Squamous-Cell-Carcinoma-Keratoacanthoma-Skin-Cancer-And-Reconstructive-Surgey-Center-Orange-County

About SCC Keratoacanthoma Type

Keratoacanthoma has been described as a benign lesion that spontaneously involutes and as a variant of squamous cell carcinoma that rarely can behave aggressively. We present a case of a keratoacanthoma-like lesion in an elderly patient that recurs invading deeply into vital structures.

Diagnosis

The diagnosis of a classic keratoacanthoma (KA) is based on clinical and histologic findings. Clinically, the classic KA appears as a nodule with a central keratin-filled crater. It has three phases of behavior:


(1) a proliferative phase of 2–10 weeks,
(2) a stationary period of 2-10 weeks, and
(3) an involution phase of up to one year duration.

 

KA has distinct histological features of keratin-filled crater lined by a proliferating squamous epithelium. Shave or incisional punch biopsies are usually inadequate to diagnose keratoacanthoma, and the definite diagnosis can only be established after tumor excision, based on the histological findings.

Treatment

Treatment of classic keratoacanthomas can be conservative given their self-limiting course and has included curettage and intralesional methotrexate.

 

The catch with KA is the association with squamous cell carcinoma (SCC) and occasional aggressive behavior. 16.7% of KA are SCC. This speaks to the significant overlap in the clinical and histological appearance of the two, which can result in misdiagnosis of SCC as KA. In addition, KA may coexist with a SCC in the same lesion, as the more aggressive cell line eventually transforms the tumor into an aggressive lesion. The development of SCC in a KA has been reported in 5.7% of KA’s. In patients older than 90 years, the transformation incidence was found to be almost 14%.

 

Metastases with KA’s are very rare even with evidence of perineural invasion. It has been suggested that perineural invasion in KA’s is less significant than in SCC.

 

Treatment of keratoacanthomas is surgery. Mohs surgery is the standard with a reported recurrence rate of 2.4%. Radiation including orthovoltage has been shown to be highly effective as well.

 

Read case study here.

 

References:
Petrie, et al. Keratoacanthoma of the Head and Neck with Perineural Invasion. Dermatol Surg 2010; 36:7: 1209-1213
Donohue, et al. Treatment of aggressive keratoacanthomas by radiotherapy. J Am Acad Dermatol 1990; 23:3: 489-493.
Larson. Keratoacanthomas treated with Mohs’ micrographic surgery. J Am Acad Dermatol 1987; 16:5: 1040-1044.
Caccialanza, et al. Radiation therapy of keratoacanthomas: results in 55 patients. Int J of Radiat Oncol Biol Phys 1989; 16:2: 475-477.
Mandrell, et al. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin in Diagnost Pathol 2009; 26:3: 150-163.
Donaldson, et al. Periocular keratoacanthoma. Ophthalmology 2003; 110:7: 1403-1407.

Management of Invasive Squamous Cell Carcinoma Arising in Bowen’s Disease
A patient presented to the SCARS Center with a nine month history of a biopsy proven Bowen’s disease of the left second toe. Mohs surgery discovered areas of invasive squamous cell carcinoma arising from Bowen’s disease within the lesion. After completing Mohs surgery, additional deep soft tissue and phalanx bone were resected to insure tumor…
Read More
Management of Non-Healing Lesion
HISTORY An 85-year-old man with a history of multiple BCC and SCC of the scalp previously treated with radiation and intralesional 5-FU presents with a non healing lesion of the left parietal scalp. Shave biopsy of the left parietal scalp performed on 7/21/21 showed a non specific ulcer with atypical squamous epithelium of the scalp.…
Read More
Managing Eyelid Skin Cancer
HISTORY A 53-year-old man presented with an approximately 10-year history of right upper eyelid “psoriasis.” He was treated with alclometasone dipropionate 0.05% ointment which helped with redness but flaking was still present. Trial of Protopic 0.1% ointment on 1/23/20 with minimal relief. Punch biopsy of the right upper eyelid on 5/19/21 showed inflamed AK. Area…
Read More
Multiple Cutaneous Carcinomas in Organ Transplant Recipients
HISTORY  A 73-year-old kidney transplant recipient presented with multiple carcinomas including SCC, SCC in situ, and BCC of the face and scalp. DISCUSSION Organ transplant recipients can suffer from multiple cutaneous carcinomas. Some lesions can have a high risk of metastases, but most occur in multitudes in areas of extensive sun exposure. At SCARS Center,…
Read More
Intralesional 5-fluorouracil for Cutaneous BCC and SCC
HISTORY  An 86-year-old man on hemodialysis with multiple medical problems and on warfarin presented with two carcinomas of the nasal tip: BCC of the left nasal tip and SCC of the right nasal tip. The ulceration of the right SCC exposed the alar cartilage. Patient completed six (6) 5-fluorouracil injections over a 5-week period. Complete…
Read More
Sentinel Lymph Node Biopsy for Cutaneous SCC
HISTORY A 58-year-old kidney transplant recipient presented with a 6-month history of squamous cell carcinoma of the left scalp. This large lesion was adjacent to the scar of a previous carcinoma excision in 2014. Patient is on sirolimus for his kidney transplant performed in 1984. He has had multiple BCCs and SCCs of scalp, back,…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.